(Total Views: 663)
Posted On: 01/02/2021 1:28:54 AM
Post# of 156263
Re: ClosetInvestor #70825
Another case saying EUAs take time: OncoImmune's CD24Fc (now Merck SACCOVID) had it's trial ended early for efficacy in September. Last week there was a Merck PR referring to the drug's "anticipated EUA" of similar wording.
(3)
(0)
